Cushing'S Syndrome Clinical Trials 2023

Cushing'S Syndrome Clinical Trials 2023

Cushing'S Syndrome research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in cushing's syndrome clinical trials today.

Cushing'S Syndrome Clinical Trials

Here are the 6 most popular medical studies for cushing's syndrome

Popular filter options for cushing's syndrome trials

Congenital Adrenal Hyperplasia Clinical Trials

View 8 Congenital Adrenal Hyperplasia medical studies.

CAH Clinical Trials

View 8 CAH medical studies.

Cushing's Syndrome Clinical Trials With No Placebo

View 20 cushing's syndrome medical studies that do not have a placebo group.

View More Cushing's Syndrome Trials

Another medical study focused on cushing's syndrome.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to cushing's syndrome

What are the top hospitals conducting cushing's syndrome research?

In the ongoing quest to find effective treatments for Cushing's syndrome, several hospitals have emerged as leaders in conducting clinical trials. The National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), located in Bethesda, is at the forefront with one active trial dedicated to this rare condition. Just recently, in 2023, they recorded their first-ever clinical trial specifically focused on Cushing's syndrome. In Canton, Ohio, Diabetes and Endocrinology Associates of Stark County Inc. also joins the ranks with one ongoing trial and a notable accomplishment of recording their inaugural Cushing's syndrome trial in 2022.

Meanwhile, St. Joseph's Hospital and Medical Center - Barrow Neurological Institute - Pituitary Center in Phoenix has established itself as another top institution by actively participating in research through one current cushing’s syndrome trial while commencing their initial investigation into this field just last year. Similarly contributing to these efforts is UCLA in Los Angeles where researchers are currently conducting an active cushing’s syndrome clinical trial after launching their first study on this condition back in 2022.

Lastly but no less significant is Southwest General Healthcare Center situated amidst Fort Myers' medical landscape which proves its commitment towards fighting against Cushing's Syndrome by carrying out two all-time trials along with one presently running test since embarking upon it only three years ago during 2022.

These hospitals show that even though Cushing's syndrome may be rare and challenging to treat effectively, there are dedicated medical professionals working tirelessly across the United States to explore new possibilities through cutting-edge research efforts. With each step forward taken by these institutions' clinical trials comes renewed hope for individuals living with this complex disorder

Which are the best cities for cushing's syndrome clinical trials?

When it comes to clinical trials for Cushing's syndrome, several cities have emerged as top destinations for research and development. Indianapolis, Indiana; New york, New York; Pittsburgh, Pennsylvania; Chicago, Illinois; and Saint Louis, Missouri all offer a range of active trials focused on investigating potential treatments such as SPI-62, relacorilant, osilodrostat, and others. These cities provide individuals with access to cutting-edge clinical trials that aim to advance our understanding of Cushing's syndrome and improve patient care outcomes.

Which are the top treatments for cushing's syndrome being explored in clinical trials?

Clinical trials for Cushing's syndrome have brought forth several promising treatments. One such treatment is SPI-62, currently being explored in one active trial and marking its first listing in 2022. Another contender is relacorilant, making waves with its involvement in one ongoing trial and two all-time clinical trials since it was introduced in 2018. Lastly, osilodrostat has also shown potential, with one active trial and a debut on the scene alongside relacorilant in 2018. These innovative treatments offer hope to individuals suffering from Cushing's syndrome by paving the way for improved management of this challenging condition.

What are the most recent clinical trials for cushing's syndrome?

Exciting advancements have been made in recent clinical trials for Cushing's syndrome, offering hope for improved treatments. Among these trials is the investigation of multiple ascending doses to assess their effectiveness in managing Cushing's syndrome. Another promising study focuses on SPI-62 and its potential therapeutic benefits. Additionally, relacorilant has advanced to phase 3 trials, demonstrating promising results as a future treatment option for this challenging condition. Osilodrostat and relacorilant are also being explored further in phase 2 studies. These ongoing trials offer great promise for individuals living with Cushing's syndrome by expanding our understanding of potential treatment options that may alleviate symptoms and improve quality of life.

What cushing's syndrome clinical trials were recently completed?

In January 2019, a significant clinical trial investigating the effectiveness of Levoketoconazole in treating Cushing's syndrome was successfully completed. This trial, sponsored by Cortendo AB, represents an important milestone in the pursuit of improved therapies for individuals suffering from this challenging condition. The results and findings from this study contribute to our understanding of potential treatment options and offer hope for patients afflicted with Cushing's syndrome.